Author: Prvulovic David Hampel Harald Pantel Johannes
Publisher: Informa Healthcare
ISSN: 1742-5255
Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.3, 2010-03, pp. : 345-354
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Naturalistic Study of Galantamine for Alzheimer's Disease
CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. :
Galantamine: A Review of its Use in Alzheimer's Disease
Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. :
Galantamine Extended Release in Alzheimer's Disease: Profile Report
By Robinson Dean M. Plosker Greg L.
Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. :
Galantamine vs Donepezil in the Treatment of Alzheimer's Disease
By Goldlist B. Gordon M. Naglie G.
Drugs & Aging, Vol. 20, Iss. 15, 2003-01 ,pp. :